Kala Pharmaceuticals, Inc.
KALA
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-teā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.71
Price-2.66%
-$0.02
1Y
Price
Market Cap
$5.012m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$254k
-
1y CAGR-33.3%
3y CAGR-41.3%
5y CAGREarnings
-$37.227m
+3.3%
1y CAGR+6.0%
3y CAGR+21.6%
5y CAGREPS
-$6.79
+2.7%
1y CAGR+34.6%
3y CAGR+44.2%
5y CAGRBook Value
-$3.206m
$36.053m
Assets$39.259m
Liabilities$11.144m
DebtDebt to Assets
30.9%
-0.3x
Debt to EBITDAFree Cash Flow
-$25.901m
+12.5%
1y CAGR+24.3%
3y CAGR+25.0%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company